A new study by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system shows that people who have been infected with COVID-19 are at an increased risk of developing a range of gastrointestinal conditions within the first month to a year after illness.
Now, in a surprising new discovery, Harvard Medical School researchers have found that a class of regulatory T cells (Tregs) made in the gut play a role in repairing injured muscles and mending damaged livers. In an even more unexpected twist, the researchers found that gut microbes fuel the production of Tregs, which act as immune healers that go on patrol around the body and respond to distress signals from distant sites of injury.
Is unsedated transnasal esophagoscopy safe for patients with cirrhosis? How good is ultrasound at assessing fibrosis in children with fatty liver disease? These are just a few of the questions addressed in presentations this past fall by faculty from the Division of Gastroenterology, Hepatology and Nutrition at Children’s Hospital Los Angeles.
When parts of the liver are removed, the body can replace the missing tissue.
The Center for Liver and Hepatobiliary Diseases at Mercy in conjunction with the University of Maryland Medical Center (UMMC) assists patients through the liver transplant process.
Researchers from the Organoid group (former Clevers group, Hubrecht Institute) together with researchers from the Princess Máxima Center for pediatric oncology established novel human organoid models of fatty liver disease.
As a child in Beirut, Ahmad Anouti, M.D., endured dozens of medical procedures, hundreds of medications, and numerous setbacks before a liver transplant at age 16 saved his life. Today, Dr. Anouti is a postdoctoral research fellow at UT Southwestern Medical Center specializing in hepatology.
Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.
Living donation and significantly lower wait times helped the program to perform 35 liver transplants in 2022. Children’s Hospital Los Angeles leads the nation in liver transplants performed at a pediatric center, according to new data released from the Organ Procurement & Transplantation Network (OPTN), which oversees organ transplants in the U.
Nutrition researchers studied 80 people with nonalcoholic fatty liver disease and found that those who followed an alternate-day fasting diet and exercised were able to improve their health. In Cell Metabolism, the researchers report that over a period of three months people in the intervention saw increased insulin sensitivity and decreased liver fat, weight and ALT, or alanine transaminase enzymes, which are markers for liver disease.
The University of Chicago Medicine liver transplant teams performed their 2,000th liver transplant in 2022, a milestone figure for the South Side academic medical center.
Cleveland Clinic performed 1,050 transplants in 2022, including heart, kidney, liver, intestine and lung transplants, as well as living donor transplantation for kidney and liver. That is up 1% from the number of transplants performed at Cleveland Clinic in 2021.
University of Virginia School of Medicine researchers have discovered a key trigger for non-alcoholic fatty liver disease, a mysterious condition that causes fat to build up in the liver for no clear reason.
A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease – alcohol-associated hepatitis.
Penn State College of Medicine researchers confirmed exercise can lead to meaningful reductions in liver fat for patients with nonalcoholic fatty liver disease.
Tuomas Sandholm’s work since 2010 to improve the fairness and effectiveness of organ donations using PSC supercomputers has won the 2023 AAAI Award for Artificial Intelligence for the Benefit of Humanity.
Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.
Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.
The American Association for the Study of Liver Diseases (AASLD) is pleased to announce that Dr. Joseph K. Lim, MD, FAASLD of Yale University will serve as the next Editor-in-Chief of Clinical Liver Disease (CLD), a free multimedia review journal that aims to provide education for clinicians diagnosing and managing patients with liver disease.
Researchers at the Francis Crick Institute and King’s College London have created a tool to predict the effects of different diets on both cancerous cells and healthy cells.
In support of our unwavering commitment to champion diversity, equity and inclusion in the field of hepatology, AASLD is pleased to announce the development of our own hepatology award.
An increase in "deaths of despair" in recent decades has been frequently portrayed as a phenomenon affecting white communities, but a new analysis in The Lancet shows the toll has been greater on Native Americans.
Join the greatest minds in hepatology across the continent for a game-changing two-day event, the 2023 North American Viral Hepatitis Elimination Summit, on March 24-25 in Los Angeles.
A first-of-its-kind study identifies mechanisms that explain how a drug commonly used to treat HIV and hepatitis causes kidney disease and kidney injury. The study is published ahead of print in Function.
Although rare compared to adult liver cancers, hepatoblastoma is the most common pediatric liver malignancy, and its incidence is increasing.
Scientists at Ningbo University, China have identified biomarkers that could provide an early warning system for three common and dangerous pregnancy complications: pre-eclampsia, gestational diabetes, and a liver condition called intrahepatic cholestasis.
Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.
A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology found that eating fast food is associated with nonalcoholic fatty liver disease, a potentially life-threatening condition in which fat builds up in the liver.
The January issue of AJG features two ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease (2013 update) and Diagnosis and Management of Gastrointestinal Subepithelial Lesions (new).
A group of international researchers is calling for revised guidelines to help improve access to hepatitis B treatment in Africa.
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
Research has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug. The study, published in the Proceedings of the National Academy of Sciences, has the potential to transform treatment for this rare disease and may also have implications for more common diseases.
Using the latest technologies—including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD). The research was led by investigators at the Icahn School of Medicine at Mount Sinai. Utilizing these innovative methods, the investigators discovered a network of cell-to-cell communication driving scarring as liver disease advances. The findings, published online on January 4 in Science Translational Medicine, could lead to new treatments.
Mountainside Medical Group has announced that gastroenterologist Masood Rizvi, M.D., has joined the practice.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.
In a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, scientists at the Roger Williams Institute of Hepatology, affiliated to King’s College London and the University of Lausanne, found an accumulation of fat in the liver causes a decrease in oxygen to the brain and inflammation to brain tissue – both of which have been proven to lead to the onset of severe brain diseases.
Algal blooms or cylindrospermopsin, exacerbated by climate change, shown to have a connection with several adverse health effects.
A brief roundup of news and story ideas from the experts at UCLA Health.
In light of the recent pandemic, people across the globe are increasingly becoming aware of the importance of consistent high-quality nutrition and daily exercise.
For patients with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF), the toxins that build up in their blood can cause confusion, tremors, vomiting, abdominal pain and stomach swelling. Having a liver unable to clean the body's blood is a life-threatening condition, and patients are told to seek immediate medical assistance.
The December issue of The American Journal of Gastroenterology features multi-society collaborations on diversity, equity, and inclusion, as well as the role of the GI profession in climate change issues. Interestingly, this issue includes a thought-provoking line of inquiry from Brennan Spiegel, MD, MSHS, FACG, who hypothesizes that gravity may play a role in IBS.
A Rutgers analysis showed that early signs of liver damage from high-dose green tea extract were somewhat predicted by one variation in a genotype and strongly predicted by another variation.
Patients with inflammatory bowel diseases (IBD) who required treatment and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.
Debashish Bose, M.D., PhD, FACS, Medical Director of Surgical Oncology at Mercy and The Center for Hepatobiliary Disease at Mercy, is the guest for the hospital’s ongoing talk show series, “Medoscopy,” airing on Facebook Watch, Tues.-Wed., Nov. 29th and 30th at 5:30 p.m. EST
Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.
A Rutgers study of obese adults, all with nonalcoholic fatty liver disease (NAFLD) and morbid obesity (body mass index > 40), has shown that those who underwent bariatric surgery suffered far fewer extreme cardiovascular events subsequently.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
